Analysis of Memory and Effector CD8 + T Cell Subsets in Chronic Graft-versus-Host Disease

Abstract

In humans, the selective depletion of CD8⁺ cells may prevent GVHD after allogeneic transplantation. These cells can infiltrate and damage target tissues. It is of interest to investigate the phenotypical characteristics and cytotoxic properties of the different CD8⁺ subsets in cGVHD patients. In a preliminary study we found that patients with cGVHD had a markedly elevated percentage of peripheral blood CCR7⁻/CD45RA⁺ cells compared to patients without cGVHD; conversely, the CCR7⁺/CD45RA⁺ subsets of CD8⁺ cells was significantly decreased. In this study, we report in depth on the phenotype of effector T cell subsets in cGVHD patients, as well as their proliferative capability, cytotoxic properties and cellular turnover. We confirm a predominance of effector T cell subsets in cGVHD patients and show that a large fraction of these cells down-regulate CCR7 and re-express CD45RA, thus approaching end-stage differentiation. Moreover CD8⁺ cells of cGVHD patients have low CD8 coreceptor expression, reduced proliferative potential and a high content of perforin and granzyme A. They also have a lower cell turnover and have more propensity to apoptosis, as demonstrated by BrdU incorporation. Taken together, our findings indicate a perturbation of the balance between naive/memory and effector/CD45RA⁺ CD8⁺ T cells, and suggest an involvement of the latter compartment characterized by a high content of cytotoxic equipment, in the pathogenesis of cGVHD.

Keywords

human T cells cytotoxic graft versus host disease

References

Shlomchik

. Graft-versus-host disease. Nat Rev Immunol 2007; 7:340–52.

Zhang

Todorov

Zhang

. Donor CD4+ and B cells in transplants induce chronic graft versus host disease with autoimmune manifestations. Blood 2006; 107:2993–3001.

Kansu

. The pathophysiology of chronic graft-versus-host disease. Int J Hemat 2004; 79:209–15.

Socié

. Chronic graft-versus-host disease: Clinical features and grading systems. Int J Hemat 2004; 79:216–20.

Yamashita

Choi

Woltz

. Severe chronic graft-versus-host disease is characterized by a preponderance of CD4+ effector memory cells relative to central memory cells. Blood 2004; 103:3986–8.

Cerottini

MacDonald

. The cellular basis of T-cell memory. Annu Rev Immunol 1989; 7:77–89.

Wherry

Teichgräber

Becker

. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003; 4:225–34.

D'Asaro

Dieli

Caccamo

Musso

Porretto

Salerno

. Increase of CCR7- CD45RA+ CD8 T cells (TEMRA) in chronic graft-versus-host disease. Leukemia 2006; 20:545–7.

Filipovich

Weisdorf

Pavletic

. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant 2005; 11:945–55.

10.

Kroger

Alexander-Miller

. Dose-dependent modulation of CD8 and functional avidity as a result of peptide encounter. Immunology 2007; 122:167–78.

11.

Zhang

Joe

Hexner

Zhu

Emerson

. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease. J Immunol 2005; 174:3051–8.

12.

Shlomchik

Matte

Liu

Jain

McNiff

. CD8+ but not CD4 T cells require cognate interactions with target tissue to mediate GVHD across only minor H antigen but CD4 and CD8 T cells both require direct leukemic contact for GVL. Blood 2005; 106(ASH Annual Meeting Abstract), Abstract 580.

13.

Sprent

Schaefer

Korngold

. Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. J Exp Med 1986; 163:998–1011.

14.

Sprent

Schaefer

Gao

Korngold

. Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hosts. J Exp Med 1988; 167:556–69.

15.

Hamilton

. L3T4-positive T cells participate in the induction of graft-vs-host disease in response to minor histocompatibility antigens. J Immunol 1987; 139:2511–5.

16.

Korngold

Sprent

. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences. J Immunol 1985; 135:3004–10.

17.

Korngold

Sprent

. Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice. J Exp Med 1987; 6:1552–64.

18.

Sprent

Korngold

. T cell subsets controlling graft-v-host disease in mice. Transplant Proc 1987; 19:41–7.

19.

Hollander

Widmer

Burakoff

. Loss of normal thymic repertoire and persistence of autoreactive T cells in graft vs host disease. J Immunol 1994; 152:1609–17.

20.

Gallardo

García-López

Sureda

. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase. Bone Marrow Transplant 1997; 20:945–52.

21.

Champlin

Gajewski

. Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation. Blood 1990; 76:418–23.

22.

Blaser

Roychowdhury

Kim

. Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease. Blood 2005; 105:894–901.

23.

Roychowdhury

Blaser

Freud

. IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease. Blood 2005; 106:2433–5.

24.

Champagne

Ogg

King

. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001; 410:106–11.

25.

Geginat

Lanzavecchia

Sallusto

. Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 2003; 101:4260–6.

26.

Charles

Kroger

Alexander-Miller

. Dose-dependent modulation of CD8 and functional avidity as a result of peptide encounter. Immunology 2007; 122:167–78.

27.

Maile

Siler

Kerry

Midkiff

Collins

Frelinger

. Peripheral CD8-tuning dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo. J. Immunol 2005; 174:619–27.

28.

Maile

Pop

Tisch

Collins

Cairns

Frelinger

. Low-avidity CD8^lo T cells induced by incomplete antigen stimulation in vivo regulate naive higher avidity CD8^hi T cell responses to the same antigen. Eur J Immunol 2006; 36:397–410.

29.

Kienzle

Olver

Buttigieg

. Progressive differentiation and commitment of CD8+ T cells to a poorly cytolytic CD8low phenotype in the presence of IL-4. J Immunol 2005; 174:2021–9.

30.

Kienzle

Baz

Kelso

. Profiling the CD81ow phenotype, an alternative career choice for CD8 T cells during primary differentiation. Immunol Cell Biol 2004; 82:75–83.

31.

Dunne

Faint

Gudgeon

. Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential. Blood 2002; 100:933–40.